Real-World Evidence Circles

12/12/2025

Truth, not scarcity, defines medical data’s value. Circle Health Coin rewards verified, ethical truth for real worth in healthcare:

Circle Coin shifts healthcare data valuation from scarcity to verified truth, turning integrity into economic and moral capital through transparent, trust-based systems.

12/09/2025

𝐖𝐡𝐲 𝐔𝐧𝐯𝐞𝐫𝐢𝐟𝐢𝐞𝐝 𝐃𝐚𝐭𝐚 𝐈𝐬 𝐭𝐡𝐞 𝐍𝐞𝐱𝐭 𝐌𝐚𝐥𝐩𝐫𝐚𝐜𝐭𝐢𝐜𝐞 𝐑𝐢𝐬𝐤 𝐢𝐧 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐀𝐈

AI is transforming healthcare, but with innovation comes liability. When algorithms misdiagnose, the fault may not lie with the clinician or the developer — it starts upstream, in the data. Every mislabeled record, every undocumented adjustment embeds risk into the model. Courts and regulators are already redefining causation: defective data can now equal negligence. The future belongs to systems that can not only predict — but testify. Are you ready for the era of auditable provenance?

Unverified healthcare data increases liability risks. Federated datasets with proven provenance enhance transparency, accountability, and trust in AI-driven medicine.

12/09/2025

𝐃𝐫𝐢𝐯𝐢𝐧𝐠 𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧 𝐢𝐧 𝐏𝐞𝐩𝐭𝐢𝐝𝐞 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐓𝐡𝐫𝐨𝐮𝐠𝐡 𝐂𝐨𝐥𝐥𝐚𝐛𝐨𝐫𝐚𝐭𝐢𝐨𝐧

At RegenMed, we’re proud to support initiatives that accelerate discovery and improve . Collaboration is the cornerstone of progress, and the recent 𝐀𝐌𝐌𝐆 𝐂𝐨𝐧𝐟𝐞𝐫𝐞𝐧𝐜𝐞 highlighted just how powerful it can be.
Grant Pagdin and the 𝐂𝐚𝐧𝐚𝐝𝐢𝐚𝐧 𝐏𝐞𝐩𝐭𝐢𝐝𝐞 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐒𝐨𝐜𝐢𝐞𝐭𝐲 (𝐂𝐏𝐑𝐒) shared an inspiring vision: establishing a 𝐍𝐨𝐫𝐭𝐡 𝐀𝐦𝐞𝐫𝐢𝐜𝐚𝐧 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐒𝐨𝐜𝐢𝐞𝐭𝐲 to unite efforts across the U.S. and Canada. This initiative aims to streamline IRB approvals through partners like Advarra, standardize treatment protocols, and strengthen data collection — critical steps toward advancing peptide science.

𝐖𝐡𝐲 𝐓𝐡𝐢𝐬 𝐌𝐚𝐭𝐭𝐞𝐫𝐬:
✔ Building bridges between clinicians and researchers
✔ Driving hypothesis-based studies in autoimmunity, orthopedics, dermatology & more
✔ Creating consensus and best practices through real-world evidence

Discover how you can get involved and find all the details on CPRS exclusive membership offer: https://www.rgnmed.com/post/advancing-peptide-research-through-collaboration

12/04/2025

The University of Wisconsin/Madison enjoys a strong global reputation for medical discovery as well as computer science – a powerful match for RegenMed’s value propositions. We were therefore honored this past summer to be invited to join GE Healthcare, Google, Qualcomm (among others) in designing and supporting Capstone projects undertaken by graduating data science engineers.

This past semester’s impressive work by two separate RegenMed teams was presented on December 1. Both projects – comprising polished front-end and back-end coding – will meaningfully strengthen patient outcomes survey completion on our patented Benchmarc™ platform. They will also increase patients’ visibility into their clinical progress on an individual and cohort basis.

Next semester’s Capstone teams will build on this foundation, as we evolve Benchmarc™ into a best-in-class patient-facing platform (i) incentivizing them to provide their key clinical outcomes data, (ii) enabling them to see the impact it makes on their care as well as patients like them, and (iii) provides concrete benefits for their important contributions in advancing evidence-based standards of care.

12/02/2025

𝐖𝐡𝐚𝐭 𝐢𝐟 𝐭𝐡𝐞 𝐛𝐢𝐠𝐠𝐞𝐬𝐭 𝐜𝐡𝐚𝐥𝐥𝐞𝐧𝐠𝐞 𝐢𝐧 𝐡𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐀𝐈 𝐢𝐬𝐧’𝐭 𝐭𝐡𝐞 𝐚𝐥𝐠𝐨𝐫𝐢𝐭𝐡𝐦 — 𝐢𝐭’𝐬 𝐭𝐡𝐞 𝐝𝐚𝐭𝐚?

The next era of AI in medicine won’t be won by computational power, but by 𝐝𝐚𝐭𝐚 𝐜𝐫𝐞𝐝𝐢𝐛𝐢𝐥𝐢𝐭𝐲. Today, over 60% of healthcare AI projects fail — not because the models are wrong, but because the data behind them can’t be trusted.

𝐍𝐨𝐧-𝐫𝐞𝐩𝐫𝐞𝐬𝐞𝐧𝐭𝐚𝐭𝐢𝐯𝐞. 𝐍𝐨𝐧-𝐯𝐞𝐫𝐢𝐟𝐢𝐚𝐛𝐥𝐞. 𝐍𝐨𝐧-𝐜𝐨𝐦𝐩𝐥𝐢𝐚𝐧𝐭. These are the hidden risks that turn promising AI into costly failures.

Regulators are raising the bar: “𝐂𝐚𝐧 𝐲𝐨𝐮 𝐩𝐫𝐨𝐯𝐞 𝐡𝐨𝐰 𝐲𝐨𝐮𝐫 𝐦𝐨𝐝𝐞𝐥 𝐥𝐞𝐚𝐫𝐧𝐞𝐝?” The answer lies in structured, auditable data — where every dataset is sourced, validated, and ready for real-world impact.

At , we’re building the foundation for that scales with integrity. Because in healthcare, 𝐭𝐫𝐮𝐬𝐭 𝐢𝐬𝐧’𝐭 𝐨𝐩𝐭𝐢𝐨𝐧𝐚𝐥 — 𝐢𝐭’𝐬 𝐭𝐡𝐞 𝐨𝐧𝐥𝐲 𝐦𝐞𝐭𝐫𝐢𝐜 𝐭𝐡𝐚𝐭 𝐦𝐚𝐭𝐭𝐞𝐫𝐬.

Discover how verifiable data is reshaping healthcare AI:

Healthcare AI's success now hinges on data credibility, regulatory compliance, and verifiable datasets — driving safer, more reliable medical innovation.

11/25/2025

The modern research enterprise has evolved into an industrialized system prioritizing output over genuine discovery. Laboratories now function like factories, with scientists as line workers managing metrics instead of curiosity. This shift stifles creativity, rewards compliance, and produces safe — yet spiritually vacant — science. To reignite true innovation, institutions must restore the craft of inquiry, valuing intellectual risk and deep exploration over volume.

Discover in the article how research can reclaim its artisan ethos and transform scientific progress:

Industrialization in science hampers innovation by prioritizing metrics over curiosity. Discover strategies to restore the craft of inquiry and foster genuine scientific progress.

11/20/2025

𝐓𝐡𝐞 𝐃𝐚𝐭𝐚 𝐏𝐚𝐫𝐚𝐝𝐨𝐱 𝐢𝐧 𝐌𝐨𝐝𝐞𝐫𝐧 𝐌𝐞𝐝𝐢𝐜𝐢𝐧𝐞: 𝐖𝐡𝐲 𝐂𝐢𝐫𝐜𝐥𝐞 𝐂𝐨𝐢𝐧 𝐌𝐚𝐭𝐭𝐞𝐫𝐬

Medicine once measured to understand. Today, it measures to exist. Hospitals, devices, and platforms capture every signal, every second — believing that more data means more truth. But here’s the paradox: 𝐭𝐡𝐞 𝐦𝐨𝐫𝐞 𝐰𝐞 𝐜𝐨𝐥𝐥𝐞𝐜𝐭, 𝐭𝐡𝐞 𝐥𝐞𝐬𝐬 𝐰𝐞 𝐤𝐧𝐨𝐰.

Dashboards multiply. Insight disappears. Quantity masquerades as quality. One false value replicated across millions of records looks like truth — but isn’t.

𝐂𝐢𝐫𝐜𝐥𝐞 𝐂𝐨𝐢𝐧 𝐜𝐡𝐚𝐧𝐠𝐞𝐬 𝐭𝐡𝐞 𝐠𝐚𝐦𝐞.

✔️𝐃𝐞𝐩𝐭𝐡 𝐨𝐯𝐞𝐫 𝐛𝐫𝐞𝐚𝐝𝐭𝐡: A single verified record outranks thousands of orphaned entries.
✔️𝐃𝐞𝐟𝐥𝐚𝐭𝐢𝐨𝐧𝐚𝐫𝐲 𝐞𝐭𝐡𝐢𝐜𝐬: Verified truth becomes scarce — and valuable.
✔️𝐕𝐞𝐫𝐢𝐟𝐢𝐜𝐚𝐭𝐢𝐨𝐧 𝐫𝐞𝐩𝐥𝐚𝐜𝐞𝐬 𝐯𝐚𝐧𝐢𝐭𝐲: Data worth lies not in its weight, but in its witness.

When proof becomes currency, medicine remembers its purpose: not to see more, but to see accurately enough to care.

👉 Learn how Circle Coin restores integrity to healthcare data.

Circle Coin redefines healthcare data by valuing verified truth over volume, combating data vanity, and restoring integrity to medical measurement for better patient outcomes.

11/18/2025

Despite cutting-edge algorithms, many AI models in healthcare falter in real-world application — not because of complexity, but due to poor data foundations. Incomplete, biased, or unverified data creates fragile systems that can mislead clinicians and endanger patients.

𝐓𝐡𝐞 𝐤𝐞𝐲 𝐭𝐨 𝐭𝐫𝐮𝐬𝐭𝐰𝐨𝐫𝐭𝐡𝐲 𝐀𝐈 𝐥𝐢𝐞𝐬 𝐢𝐧 𝐠𝐨𝐯𝐞𝐫𝐧𝐚𝐧𝐜𝐞:

✔️Transparent data lineage
✔️Continuous validation
✔️Verifiable provenance

Innovative approaches like Circle Datasets prioritize integrity at the source, reducing downstream risks and costs. True resilience in medical AI emerges when governance is embedded into the architecture — transforming data from a liability into a reliable asset.

The path to smarter, safer healthcare starts with accountable data. Are we ready to treat data as a regulated, auditable instrument?

Effective healthcare AI requires robust data governance, provenance, and validation. Building trust and resilience is essential for safe, accurate medical decision-making.

11/14/2025

𝐑𝐞𝐠𝐞𝐧𝐌𝐞𝐝, 𝐈𝐧𝐜. 𝐀𝐧𝐧𝐨𝐮𝐧𝐜𝐞𝐬 𝐒𝐭𝐫𝐚𝐭𝐞𝐠𝐢𝐜 𝐓𝐞𝐜𝐡𝐧𝐢𝐜𝐚𝐥 𝐏𝐚𝐫𝐭𝐧𝐞𝐫𝐬𝐡𝐢𝐩 𝐖𝐢𝐭𝐡 𝐈𝐏𝐑𝐃 𝐒𝐨𝐥𝐮𝐭𝐢𝐨𝐧𝐬

RegenMed is pleased to announce a strategic partnership with IPRD Solutions, a leading global provider of enterprise-level healthcare data solutions. This partnership will further accelerate the development of our patented technical platform to optimize Circle Datasets for AI healthcare models, federated data capture, and the tokenization of consented personal health records. (RegenMed’s White Papers on each of these three foundational topics are available here: https://hubs.li/Q03Tl2FF0.)

IPRD brings to the partnership deep healthcare IT architecting and coding sophistication. It has worked closely with Google, the Gates Foundation, Pew Charitable Trusts, the World Health Organization and major U.S. hospital systems. IPRD’s senior management has deep roots in, and maintains close relationships with, SRI International, IBM, and other major institutions at the forefront of modern healthcare data architecture.

RegenMed looks forward to reporting on significant technical milestones further enabling Circles to revolutionize the efficient generation and accessibility of clinically-impactful, statistically significant and fully verifiable/consented healthcare datasets.

11/13/2025

In healthcare, trust is the new currency for success. Discover how verifiable data provenance and transparency are transforming clinician confidence, regulatory compliance, and investment in AI. Building credibility isn’t about more technology — it's about ensuring trust through proven provenance. Read more to learn why verification is the key to unlocking AI’s full potential in healthcare: https://hubs.li/Q03SZdch0

11/12/2025

𝐓𝐡𝐞 𝐅𝐮𝐭𝐮𝐫𝐞 𝐨𝐟 𝐌𝐞𝐝𝐢𝐜𝐢𝐧𝐞 𝐢𝐬 𝐇𝐞𝐫𝐞: 𝐏𝐞𝐩𝐭𝐢𝐝𝐞𝐬 𝐋𝐞𝐚𝐝𝐢𝐧𝐠 𝐭𝐡𝐞 𝐂𝐡𝐚𝐫𝐠𝐞!

Did you know that over 11% of new pharmaceutical approvals by the FDA from 2016–2024 were synthetic peptides? In 2023 alone, peptides made up 16.3% of novel therapeutics, showcasing their rapidly growing role in innovative healthcare solutions.

CPRS is at the forefront of this revolution — bringing together clinicians, researchers, and industry leaders to accelerate peptide science. From regenerative medicine to autoimmune therapies, peptides are transforming personalized treatment options and patient outcomes.

𝐖𝐡𝐲 𝐉𝐨𝐢𝐧 𝐂𝐏𝐑𝐒?

✅Access cutting-edge research and white papers
✅Influence clinical guidelines
✅Network with pioneers in peptide science
✅Participate in exclusive workshops and webinars

📅 Don't miss the upcoming conference in Salt Lake City, November 12-16, where experts like Dr. Pagdin will explore how peptides can revolutionize patient care.

Join the movement today and be part of shaping the future of medicine. Together, we can unlock the full potential of peptides for better health worldwide.

Learn more:

Synthetic peptides now represent over 11% of FDA-approved drugs (2016–2024), revolutionizing personalized medicine with applications in autoimmunity, regeneration, and more.